Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.66), $0.20 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $30.03 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.